Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
Othman Al‐Sawaf, Sandra Robrecht, Jasmin Bahlo, et al.
Leukemia (2020) Vol. 35, Iss. 1, pp. 169-176
Closed Access | Times Cited: 85

Showing 26-50 of 85 citing articles:

Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter’s transformation
Oscar Lahoud, Sean M. Devlin, Molly Maloy, et al.
Blood Advances (2021) Vol. 5, Iss. 14, pp. 2879-2889
Open Access | Times Cited: 22
DA-R-EPOCH vs R-CHOP in DLBCL: How do we choose?
Ajay Major, Sonali M. Smith
PubMed (2021) Vol. 19, Iss. 11, pp. 698-709
Closed Access | Times Cited: 22
Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents
Tamar Tadmor, Ilana Levy
Cancers (2021) Vol. 13, Iss. 20, pp. 5141-5141
Open Access | Times Cited: 21
Emerging Therapies for the Management of Richter Transformation
Elizabeth Smyth, Toby A. Eyre, Chan Y. Cheah
Journal of Clinical Oncology (2022) Vol. 41, Iss. 2, pp. 395-409
Closed Access | Times Cited: 15
DLBCL arising from indolent lymphomas: How are they different?
Erin M. Parry, Sandrine Roulland, Jessica Okosun
Seminars in Hematology (2023) Vol. 60, Iss. 5, pp. 277-284
Open Access | Times Cited: 9
Practical Management of Richter Transformation in 2023 and Beyond
Christine E. Ryan, Matthew S. Davids
American Society of Clinical Oncology Educational Book (2023), Iss. 43
Closed Access | Times Cited: 8
Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
Rebecca L. King, Alia Gupta, Paul J. Kurtin, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Allogeneic hematopoietic cell transplantation is an effective treatment for patients with Richter syndrome: A systematic review and meta-analysis
Sonikpreet Aulakh, Tea Reljic, Farah Yassine, et al.
Hematology/Oncology and Stem Cell Therapy (2020) Vol. 14, Iss. 1, pp. 33-40
Open Access | Times Cited: 20
Richter’s Transformation
Audrey M. Sigmund, Adam S. Kittai
Current Oncology Reports (2022) Vol. 24, Iss. 8, pp. 1081-1090
Closed Access | Times Cited: 11
Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib
Adam S. Kittai, Ying Huang, Kyle A. Beckwith, et al.
American Journal of Hematology (2022) Vol. 98, Iss. 1, pp. 56-65
Closed Access | Times Cited: 11
PET/CT in leukemia: utility and future directions
Akram Al‐Ibraheem, Sudqi Allouzi, Ahmed Saad Abdlkadir, et al.
Nuclear Medicine Communications (2024) Vol. 45, Iss. 7, pp. 550-563
Closed Access | Times Cited: 2
Microenvironment Remodeling and Subsequent Clinical Implications in Diffuse Large B-Cell Histologic Variant of Richter Syndrome
Hélène Augé, Anne-Béatrice Notarantonio, Romain Morizot, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 17
Richter Syndrome: From Molecular Pathogenesis to Druggable Targets
Samir Mouhssine, Gianluca Gaïdano
Cancers (2022) Vol. 14, Iss. 19, pp. 4644-4644
Open Access | Times Cited: 10
The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review
Robert Puckrin, Mona Shafey, Jan Storek
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 6
Allogeneic hematopoietic cell transplantation for Richter transformation of chronic lymphocytic leukemia: an intention-to-transplant analysis
Robert Puckrin, Carolyn Owen, Amélie Fontaine, et al.
Bone Marrow Transplantation (2023) Vol. 58, Iss. 7, pp. 817-819
Closed Access | Times Cited: 6
Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH/EAHP Workshop
Magdalena Czader, Catalina Amador, James R. Cook, et al.
American Journal of Clinical Pathology (2023) Vol. 159, Iss. 6, pp. 554-571
Open Access | Times Cited: 6
Novel Approaches for the Treatment of Patients with Richter’s Syndrome
Andrea Iannello, Silvia Deaglio, Tiziana Vaisitti
Current Treatment Options in Oncology (2022) Vol. 23, Iss. 4, pp. 526-542
Open Access | Times Cited: 9
Immunological Aspects of Richter Syndrome: From Immune Dysfunction to Immunotherapy
Abdurraouf Mokhtar Mahmoud, Gianluca Gaïdano, Samir Mouhssine
Cancers (2023) Vol. 15, Iss. 4, pp. 1015-1015
Open Access | Times Cited: 5
Outcomes of Hodgkin variant Richter transformation in chronic lymphocytic leukaemia and small lymphocytic lymphoma in British Columbia
Kai Zhu, Andrew Jamroz, Steven K. Huang, et al.
British Journal of Haematology (2022) Vol. 198, Iss. 4, pp. 684-692
Open Access | Times Cited: 8
Richter transformation of chronic lymphocytic leukaemia: a British Society for Haematology Good Practice Paper
Toby A. Eyre, John C. Riches, Piers Patten, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 4, pp. 864-870
Open Access | Times Cited: 11
Richter Transformation of Chronic Lymphocytic Leukemia—Are We Making Progress?
Hadiyah Y. Audil, Samuel Kosydar, Daniel P. Larson, et al.
Current Hematologic Malignancy Reports (2023) Vol. 18, Iss. 5, pp. 144-157
Closed Access | Times Cited: 4
From genetics to therapy: Unraveling the complexities of Richter transformation in chronic lymphocytic leukemia
Pau Abrisqueta, Ferran Nadeu, Jan Bosch‐Schips, et al.
Cancer Treatment Reviews (2023) Vol. 120, pp. 102619-102619
Open Access | Times Cited: 4
Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience
Shuchao Qin, Rui Jiang, Luomengjia Dai, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1635-1642
Open Access | Times Cited: 1
Case report: ‘Atypical Richter transformation from CLL-type monoclonal B-cell lymphocytosis into Burkitt lymphoma in a treatment naïve patient’
Annaïse Jauch, Ilaria Alborelli, Andreas Reusser, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in <i>de novo</i> large B-cell lymphoma and transformed low-grade B-cell lymphoma
Ohad Benjamini, Shalev Fried, Roni Shouval, et al.
Haematologica (2024)
Open Access | Times Cited: 1

Scroll to top